Taiwan Society of Gene Therapy_Director

DirectorSheng-Chieh Chou

Professional license
  • 2003 Taiwan Medical License
  • 2008 Certified, Taiwan, Board of Internal Medicine
  • 2010 Certified, Taiwan, Board of Hematology
Educational qualifications
  • M.D., Faculty of Medicine, Tzu-Chi Medical College, Hualien, Taiwan, 2003
Experience
  1. Lecturer of internal medicine, National Taiwan University
  2. Attending Physician/Hematologist, Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital
Areas of expertise
  1. coagulation
  2. bleeding disorder
  3. hemophilia
  4. gene therapy
Professional writings
  • Chou SC, Yen CT, Yang YL, Chen SH, Wang JD, Fan MN, Chen LF, Yu IS, Tsai DY, Lin KI, Tao MH, Wu JC, Lin SW. Recapitulating the immune system of hemophilia A patients with inhibitors using immunodeficient mice.Thromb Res. 2024; 235: 155-63. 10.1016/j.thromres.2024.01.019.
  • Mahlangu J, Kaczmarek R, von Drygalski A, Shapiro S, Chou SC, Ozelo MC, et al.Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A. New England Journal of Medicine. 2023; 388: 694-705. 10.1056/NEJMoa2211075.
  • Shen MC, Chou SC, Chiou SS, Lin PC, et al, Taiwan Society of T, Hemostasis study g. Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan. Haemophilia. 2023. 10.1111/hae.14880.
  • Chou SC, Hsu YC, Lin SW. Gene therapy for hemophilia, a clinical viewpoint. J Formos Med Assoc. 2023; 122: 1101-10. 10.1016/j.jfma.2023.05.008.
  • Chou SC, Pai CH, Lin SW, Tien HF. Incidence and risk factors for venous thromboembolism in a cohort of Taiwanese patients with lung, gastric, pancreatic cancers or lymphoma. J Formos Med Assoc. 2022; 121: 360-6.10.1016/j.jfma.2021.04.025.
  • Chou SC, Chang YC, Liao CK, Chen TC, et al New presentations and exacerbations of immune thrombocytopenia after coronavirus disease 2019 vaccinations: the Taiwan experience. Platelets. 2022; 33: 531-5. 10.1080/09537104.2022.2042237.
  • Chou SC, Lin CY, Lin HY, Pai CH, et al. Characterization of congenital factor XII deficiency in Taiwanese patients: identification of one novel and one common mutation. Int J Hematol. 2022; 116: 528-33. 10.1007/s12185-022-03390-0.
  • Chou SC, Lin CY, Yen CT, Hsieh HN, et al. Acquired FXIII inhibitor: Patient characteristics and treatment outcome, a case series in Taiwan. J Formos Med Assoc. 2021; 120: 411-4. 10.1016/j.jfma.2020.05.032.
  • Chou SC, Lin DT, Lin CY, Huang YC, et al. First reported case of congenital thrombotic thrombocytopenic purpura in Taiwan with novel mutation of ADAMTS13 gene. Int J Hematol. 2021; 113: 760-4. 10.1007/s12185-020-03068-5.
Back To List